TYK2 inhibitor identifies as a promising drug candidate for preventing type 1 diabetes News-Medical.Netsource Post navigation Novo Nordisk expected to maintain lead in diabetes market over Eli Lilly, report finds – Seeking Alpha What is the cost of diabetes? A look at the economic impact of the disease on patients – CNA